CheckMyRecalls

Medicines & drugs recalls

909 recalls since January 2025 from Health Canada, FDA, newest first. Last notice 19 Nov 2026.

Page 9 of 19

  1. TARO-CANDESARTAN: Affected lots were manufactured using an active ingredient that was out of specification for dissolutionHealth CanadaProduct quality
  2. NOVADOZ PHARMACEUTICALS LLC recalls Glycopyrrolate Oral SolutionFDAFailed Impurities/Degradation Specifications
  3. Baxter Healthcare Corporation recalls Sterile Water for IrrigationFDAPresence of particulate matter: plastic particles from the bottle rim were observed floating into the solution
  4. Haleon US Holdings LLC recalls parodontax (cetylpyridinium chloride)ACTIVE GUM HEALTHFDALabeling: Incorrect or Missing Lot and/or Exp Date: Potential for missing or illegible lot and expiration date coding on the bottles.
  5. Sato Pharmaceutical Co., Ltd recalls INON ACE Antacid tablets (magnesium aluminosilicateFDAFailed Disintegration Specifications: above the time expected.
  6. Greenstone Llc recalls methylprednisolone tabletsFDALabeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing…
  7. Updated: Great White North Growers Inc. recalls certain Lunaire brand dried cannabis products due to heavy metal contaminationHealth CanadaChemical contamination
  8. Cipla USA, Inc. recalls Diclofenac Sodium Topical GelFDAFailed PH Specifications
  9. Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl capsulesFDASubpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
  10. Graviti Pharmaceuticals Private Limited recalls Furosemide TabletsFDAPresence of Foreign Substance
  11. Specialty Process Labs LLC recalls ThyroidFDASubpotent Drug
  12. Advanced Pharmaceutical Technology, Inc. recalls TESTO-100 CIII (testosterone 100 mg)FDALack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets.
  13. SUN PHARMACEUTICAL INDUSTRIES INC recalls Clindamycin Phosphate USPFDAFailed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.
  14. Alvogen, Inc recalls Levothyroxine Sodium TabletsFDAProduct Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets.
  15. GOLD STAR DISTRIBUTION INC recalls TYLENOL a) 500 MG. and 25 moreFDACGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center.
  16. SUN PHARMACEUTICAL INDUSTRIES INC recalls Fluocinolone Acetonide Solution Topical Solution USPFDAFailed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D.
  17. Cipla USA, Inc. recalls Lanreotide InjectionFDAPresence of Particulate Matter.
  18. Encon Safety Products Co recalls AQ 120 GFEWFDACGMP deviations.
  19. BiOptimizers Magnesium Breakthrough capsules; Residue on capsulesHealth CanadaProduct quality
  20. Medinatura New Mexico, inc. recalls ClearLife Allergy Nasal Spray and 1 moreFDAMicrobial Contamination of Non-Sterile Products: The products have been found to contain yeast/mold and microbial contamination identified as…
  21. Alembic Pharmaceuticals Limited recalls Fesoterodine FumarateFDAFailed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.
  22. Signature Formulations, LLC recalls ORL Kids Mouthwash and 1 moreFDACGMP Deviations
  23. SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USPFDAFailed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
  24. Imprimis NJOF, LLC recalls Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL and 2 moreFDAPresence of particulate matter - Glass like particles.
  25. AvKARE recalls Rosuvastatin TabletsFDAOut of specification for dissolution.
  26. Octreotide for injectable suspension; Good manufacturing practices concernsHealth CanadaProduct quality
  27. Locametz powder for solution, kit; Out of specification (unknown impurity)Health CanadaProduct quality
  28. Novo Nordisk Inc. recalls Wegovy (semaglutide) InjectionFDAPresence of Particulate Matter: Hair was found in a prefilled syringe
  29. CareFusion 213, LLC recalls BD ChloraPrep" Triple Swabsticks (Chlorhexidine gluconate (CHG)FDALack of Assurance of Sterlity
  30. Zydus Pharmaceuticals (USA) Inc recalls traZODONE Hydrochloride TabletsFDAFailed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.
  31. Glenmark Pharmaceuticals Inc., USA recalls Ondansetron Orally Disintegrating TabletsFDADefective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
  32. JAMP-ASA 81 mg EC; Out of specification (salicylic acid impurity)Health CanadaProduct quality
  33. Merck Sharp & Dohme LLC recalls Merck Emend (aprepitant) for oral suspension and 1 moreFDAPresence of particulate matter: potential presence of metal particulates in the product.
  34. Golden State Medical Supply Inc. recalls Baclofen Tablets USPFDAPresence of Foreign Tablets/Capsules
  35. SOMERSET THERAPEUTICS LLC recalls Cisatracurium Besylate Injection USPFDASubpotent product:out of specification assay results observed during long term stability testing.
  36. Novocol Pharmaceutical of Canada, Inc. recalls Benco dental Graham CHEMICAL CO. and 6 moreFDADefective container: cracked/broken cartridges
  37. SUN PHARMA /TARO recalls Ciclopirox ShampooFDAFailed Impurity/Degradation specifications: OOS results obtained at the 18-month timepoint
  38. Preferred Pharmaceuticals, Inc. recalls Ondansetron ODT TabletsFDADefective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
  39. ERYTHROMYCIN OPHTHALMIC OINTMENT USP: Product sterility may be compromisedHealth CanadaProduct quality
  40. Viazen Immunity: The selenium content is out of specification in the affected batch.Health CanadaProduct quality
  41. Teva-Topilene Ointment 0.05%: The assay is potentially out of specification in the affected lot during its shelf life.Health CanadaProduct quality
  42. APO-TRAVOPROST-TIMOP PQ: missing the documented justification for the results obtained.Health CanadaProduct quality
  43. Cipla USA, Inc. recalls Lanthanum Carbonate chewable tabletsFDAFailed stability specifications: Out of specification for hardness test
  44. Lupin Pharmaceuticals Inc. recalls Sertraline Hydrochloride Tablets USPFDADefective container - seal not adhering to bottles
  45. Dr. Reddy's Laboratories, Inc. recalls Varenicline TabletsFDASub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
  46. Cipla USA, Inc. recalls Cinacalcet Hydrochloride TabletsFDACGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
  47. Lupin Pharmaceuticals Inc. recalls Ganirelix Acetate InjectionFDAFailed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
  48. Glenmark Pharmaceuticals Inc., USA recalls Nebivolol TabletsFDACross Contamination with Other Products
  49. Fagron Compounding Services recalls Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% …FDAIncorrect Product Formulation
  50. Winder Laboratories, LLC recalls Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL)FDACorrect Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.